Publication: Comparative analysis of autoantibodies against alpha-fodrin in serum, tear fluid, and saliva from patients with Sjogren's syndrome
| dc.contributor.authors | Yavuz, Sule; Toker, Ebru; Bicakcigil, Muge; Mumcu, Gonca; Cakir, Sezen | |
| dc.date.accessioned | 2022-03-12T17:18:39Z | |
| dc.date.accessioned | 2026-01-11T13:17:45Z | |
| dc.date.available | 2022-03-12T17:18:39Z | |
| dc.date.issued | 2006 | |
| dc.description.abstract | Objective. To evaluate levels of IgA and IgG antibodies against a-fodrin in serum. tear fluid. and saliva and compare them with anti-Ro and anti-La antibody levels in the same samples of patients with Sjogren's syndrome (SS). Methods. Samples from 25 patients with SS (17 primary and 8 secondary), 8 patients with systemic lupus erythematosus (SLE), and 7 patients with rheumatoid arthritis (RA) as well as 20 healthy blood donor controls were collected. Antibodies were measured using ELISA. Results. Although 40% of patients with primary SS had IgG anti-alpha-fodrin in their sera. it was also found in 36% and 32% of samples of their tear fluid and saliva. respectively. IgA alpha-fodrin antibodies were detected in 32% of SS sera. 20% of tear fluid samples. and 32% of saliva samples. Although the level of IgG anti-alpha-fodrin was significantly greater in serum, tear fluid, and saliva of SS patients compared to controls (p < 0.001), a significant difference was observed only in serum and saliva. While anti-Ro was detected in 48%. 56%, and 24% of serum, tear fluid. and saliva samples, respectively, anti-La was found in 40%. 44%, and 28%. Significant association was observed between serum IgG antibodies against a-fodrin and dry eye symptom score and rose bengal staining score. A negative association was also noted between tear IgA antibodies against alpha-fodrin and Schirmer I test. Conclusion. Correlation of IgG and IgA antibodies against alpha-fodrin with the seventy of eye involvement suggests that these autoantibodies may be considered activation markers of SS. | |
| dc.identifier.doi | doiWOS:000238872000017 | |
| dc.identifier.eissn | 1499-2752 | |
| dc.identifier.issn | 0315-162X | |
| dc.identifier.pubmed | 16821267 | |
| dc.identifier.uri | https://hdl.handle.net/11424/227992 | |
| dc.identifier.wos | WOS:000238872000017 | |
| dc.language.iso | eng | |
| dc.publisher | J RHEUMATOL PUBL CO | |
| dc.relation.ispartof | JOURNAL OF RHEUMATOLOGY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Sjogren's syndrome | |
| dc.subject | anti-alpha-fodrin antibodies | |
| dc.subject | HYDROXYCHLOROQUINE TREATMENT | |
| dc.subject | ANTIBODIES | |
| dc.subject | MARKERS | |
| dc.subject | IGA | |
| dc.title | Comparative analysis of autoantibodies against alpha-fodrin in serum, tear fluid, and saliva from patients with Sjogren's syndrome | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 1292 | |
| oaire.citation.issue | 7 | |
| oaire.citation.startPage | 1289 | |
| oaire.citation.title | JOURNAL OF RHEUMATOLOGY | |
| oaire.citation.volume | 33 |
